Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
the desire to make a meaningful impact? Human Behavior & Movement - Postdoc Fellows E-STEEM Call 2026 174 Research Services and Career Development Startdate: 01.10.2026 | Working hours: 40 | Collective
-
of Health (NIH) and the Department of Health and Human Services (DHHS). Within this program, the Section on Synapse Development Plasticity (Chief: Zheng Li, PhD, https://www.nimh.nih.gov/research/research
-
The Intramural Research Program (IRP), National Institute on Drug Abuse (NIDA), a research component of the National Institutes of Health (NIH), Department of Health and Human Services (DHHS) has
-
to Immunology research demonstrated in publications Proficiency in English and strong communication skills are necessary. Desired Qualifications In vivo research experience with rodents and human tissues
-
the development and function of organs and organisms as well as in human disease etiologies (cancer, inflammation, cardiometabolic disease, aging, immune and neurological disorders) and plant-microorganism
-
the following areas: Developing novel and widely used human genomic transgenic mouse models of HD (e.g. Gu, Neuron , 2022, PMID: 35114102; Gray, J. Neurosci., 2008, PMID: 18550760); Characterizing transcriptomic
-
, contributing significantly to education, research, innovation, and the advancement of society. The university currently encompasses 13 academic disciplines, including humanities, sciences, engineering, medicine
-
xenografts (PDXs), and human specimens to develop next-generation therapeutics. Collaborative Medicinal Research: Work in a dynamic, collaborative, and interdisciplinary research team. State-of-the-Art
-
) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest
-
interdisciplinary pipelines to identify effective RNA drugs against human diseases: AI-driven RNA discovery – using AI agents to prioritize the therapeutic potential of human lncRNAs (supported by the NHLBI